Hasil Pencarian (1)
small molecule | CAS: 1100598-32-0
Tepotinib is a MET tyrosine kinase inhibitor intended to treat a variety of MET-overexpressing solid tumors.[A228058] It was originally developed in partnership between EMD Serono and the University of Texas M.D. Anderson Cancer Center in 2009 and has since b…
Kategori:
Antineoplastic AgentsAntineoplastic and Immunomodulating AgentsBCRP/ABCG2 Inhibitors
+23
Target Protein:
Hepatocyte growth factor receptorNischarinMelatonin receptor type 1B
Waktu ParuhFollowing oral admi…
Vol. DistribusiThe mean apparent v…
KlirensThe apparent cleara…
Genetik
-